Grail (GRAL) EBITDA Margin (2023 - 2026)
Grail's (GRAL) quarterly EBITDA Margin came in at 388.89% in Q2 2026, up 5803.0% on a YoY basis from 6.59% in Q2 2025, and down 16.83% quarter-over-quarter from 332.88% in Q1 2026.
Powered by 
Analysis
Grail (GRAL) EBITDA Margin (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported EBITDA Margin for 4 consecutive years, with 388.89% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin rose 5803.0% year-over-year to 388.89%; the trailing twelve-month figure through Jun 2026 stood at 355.73% (up 11558.0% YoY), and the FY2025 full-year result was 381.98%, up 136105.0% from the prior year.
- EBITDA Margin fell to 388.89% in Q2 2026 per GRAL's latest filing, from 332.88% in the prior quarter.
- Across five years, EBITDA Margin topped out at 210.2% in Q4 2023 and bottomed at 5133.85% in Q2 2024.
- Historically, EBITDA Margin has averaged 1208.81% across 4 years, with a median of 464.7% in 2025.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin slumped 422206 bps in 2024, then soared 468693 bps in 2025.
- Over 4 years, EBITDA Margin stood at 210.2% in 2023, then slumped by 70 bps to 357.99% in 2024, then rose by 3 bps to 346.17% in 2025, then declined by 12 bps to 388.89% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 388.89%, 332.88%, and 346.17% for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -10.07% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 12.10% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 5.03% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -22.04% |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | -388.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -388.89% |
| Mar 31, 2026 | -332.88% |
| Sep 30, 2025 | -346.17% |
| Jun 30, 2025 | -446.92% |
| Mar 31, 2025 | -482.48% |
| Dec 31, 2024 | -357.99% |
| Sep 30, 2024 | -640.47% |
| Jun 30, 2024 | -5,133.85% |
| Mar 31, 2024 | -851.10% |
| Dec 31, 2023 | -210.20% |
| Oct 1, 2023 | -4,403.01% |
| Jun 30, 2023 | -911.78% |